您要查找的是不是:
- GVHD can also be a factor in donor lymphocyte infusion. 此外,GVHD也是供体淋巴细胞输注的一个因素。
- Objective:To study engraftment kinetic for directing donor lymphocyte infusion (DLI). 目的 :观察移植物动力学变化 ,指导供者淋巴细胞输注 (DL I)。
- Five patients with malignant hematonosis were received donor lymphocyte infusion(DLI) after transplantation. 对5例恶性血液病实施供者淋巴细胞输注。
- Mixed chimerism (MC) patients in group C were subjected to donor lymphocyte infusion (DLI). C组形成混合性嵌合体后行供者淋巴细胞输注(DLI)。
- A potential risk of donor lymphocyte infusion is severe graft versus host disease (GVHD). 供体淋巴细胞输注的一个潜在风险是严重的移植物抗宿主病(GVHD)。
- Methods:The clinical data of 12 cases undergoing allo-HSCT and 4 cases with donor lymphocyte infusion(DLI) were analyzed. 方法:总结12例血液病患者经allo-HSCT及4例供者淋巴细胞输注(DLI)治疗的临床资料。
- Objective To evaluate the application of donor lymphocyte infusion (DLI) after nonmyeloablative stem cell transplantation (NSCT) for hematologic malignancies. 目的探讨供者淋巴细胞输注(DLI)治疗非清髓性异基因造血干细胞移植后血液病复发的疗效。
- To explore clinical curative effect of donor lymphocyte infusion followed by non-myeloablative haemotopoietic stem cell transplantation for acute leukemia. 探讨非清髓性造血干细胞移植后供者淋巴细胞输注治疗急性白血病的疗效。
- Objective To explore clinical curative effect of donor lymphocyte infusion followed by non-myeloablative haemotopoietic stem cell transplantation for acute leukemia. 目的探讨非清髓性造血干细胞移植后供者淋巴细胞输注治疗急性白血病的疗效。
- Objective To explore the graft versus leukemia effects of donor lymphocyte infusion(DLI) after nonmyeloablative allogeneic bone marrow transplantation while attenuating treatment associated morbidity, mortality and graft versus host disease. 目的 探讨非清除性异基因骨髓移植 (allo BMT)后供者淋巴细胞输注 (DLI)是否能减少移植相关并发症、相关死亡和减轻移植物抗宿主病 (GVHD) ,是否能增强移植物抗白血病 (GVL)效应。
- Four patients experienced no acute graft-versus-host disease (GVHD) at all,one (case 1) of whom subsequently had chronic GVHD in skin after the fifth donor lymphocyte infusion (DLI) and another (case 3) had chronic GVHD after the seventh DLI. 4例均未发生急性移植物抗宿主病 ,例 1于第 5次供者淋巴细胞输注后发生皮肤慢性移植物抗宿主病 ,例 3于第 7次供者淋巴细胞输注后发生慢性移植物抗宿主病。
- ObjectiveTo evaluate the efficacy and complications of donor lymphocyte infusion (DLI) following nonmyeloablative stem cell transplantation(NSCT)for the patients with hematologic diseases. 研究非清髓性造血干细胞移植治疗血液病和供者淋巴细胞输注的疗效及并发症。
- donor lymphocyte infusion (DLI) and induced graft versus host plasma cell effect can aslo be used in the treatment of delayed erythropoiesis. 供者淋巴细胞输注及诱导移植物抗宿将细胞效应也可用于此类问题的治疗。
- Keywords nonmyeloablative allogeneic hematopoietic stem cell transplantation;donor lymphocyte infusion;chimerism;graft-versus-host disease; 非清髓性异基因造血干细胞移植;供者淋巴细胞输注;嵌合体;移植物抗宿主病;
- Keywords Haploidentical transplantation;Graft versus host disease;Graft versus tumor;nonmyeloablative stem transplantation(NST);Donor lymphocyte infusion(DLI); 单倍体相合移植;移植抗宿主病;移植物抗肿瘤;NST;DLI;
- Chronic Myeloid Leukemia ; Allogeneic Stem Cell Transplantation ; Donor Lymphocyte Infusion ; Mixed Hematopietic Chimerism ; Conditioning Regimen ; Buffy Coat ; Rejection 慢性骨髓性白血病;异体干细胞移植;捐赠者淋巴球输注;造血系统混嵌合;调理疗法;血沉棕黄层;排斥
- haematopoietic stem cell transplantation;acute leukemia;donor lymphocyte infusion;graft versus host disease(GVHD);graft versus leukemia effect;non-myeloablative 造血干细胞移植;非清髓性;供者淋巴细胞输注;急性白血病;移植物抗白血病效应;移植物抗宿主病
- Donor lymphocyte infusion 供者淋巴细胞输注
- 1.ObjectiveTo evaluate the efficacy and complications of donor lymphocyte infusion (DLI) following nonmyeloablative stem cell transplantation(NSCT)for the patients with hematologic diseases. 目的探讨供者淋巴细胞输注(DLI)治疗非清髓性异基因造血干细胞移植后血液病复发的疗效。
- Advance of Research on Treatment of Donor Lymphocyte Infusions in Relapse of Hematologic Malignancies after Allogeneic Bone Marrow Transplantation 供者淋巴细胞输注治疗异基因骨髓移植后血液恶性肿瘤复发的研究进展